Stentys SA

Type: Company
Name: Stentys SA
Nationality: United States
Fact Sheet: Fact Sheet for Stentys
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Stentys Posts First Half 2014 Revenues Results

Stentys reported revenues for the second quarter and first half of 2014, as well as cash position at June 30. In a release on July 24, the company noted that revenues increased 18.2 percent to EUR1,080 thousand in the second quarter of 2014 compared with ... [Published Individual.com - Jul 29 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

STENTYS First Half 2014 Revenues Rise 18%

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS First Half 2014 Revenues Rise 18% ... [Published Business Wire Health News - Jul 24 2014]
Entities: Stentys SA, Paris
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Study Shows Malapposition Influences Death from Early Stent Thrombosis

– Stentys has announced the publication of an article in the Journal of the American College of Cardiology (JACC) entitled, "Causes of Early Stent Thrombosis in Patients Presenting with Acute Coronary Syndrome: An Ex Vivo Human Autopsy Study."Researchers ... [Published Diagnostic & Invasive Cardiology - Jul 21 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

Stentys Bolsters Marketing of the Self-Apposing Stent in South America

Stentys reported its first distribution contracts in South America. According to a release, Stentys has established distributor agreements in Argentina, Chile and Colombia. These contracts represent the first step in Stentys' strategy to expand its commercial ... [Published Individual.com - Jul 14 2014]
First reported Jul 09 2014 - Updated Jul 10 2014 - 2 reports

STENTYS Expands Marketing of the Self-Apposing Stent in South America

PRINCETON, N.J. & PARIS--( STENTYS has established distributor agreements in Argentina, Chile and Colombia. These contracts represent the first step in STENTYS’ strategy to expand its commercial presence into the Latin American coronary stent market, ... [Published EON: Enhanced Online News - Jul 09 2014]
First reported Jun 22 2014 - Updated Jun 22 2014 - 1 reports

STENTYS : Purchases Cappella Peel Away

Stentys presented the final terms of the acquisition of Cappella Peel Away and of its assets relating to a novel stent delivery system for a total amount of EUR1 million in stock and cash.According to a release from the Company, Stentys and Cappella, ... [Published 4 Traders - Jun 22 2014]
First reported Jun 12 2014 - Updated Jun 13 2014 - 1 reports

STENTYS Completes the Acquisition of Cappella Peel Away Inc.

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS has completed its acquisition of Cappella Peel Away Inc. for a total of 1 million Euros in stock and cash. ... [Published Business Wire Health News - Jun 12 2014]
First reported Jun 04 2014 - Updated Jun 05 2014 - 1 reports

STENTYS to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing Stents

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS will acquire a catheter technology for a next-generation delivery system for its Self-Apposing Stent; it has been validated by an extensive number of Cappella Sideguard stent implants. ... [Published Business Wire Health News - Jun 04 2014]
First reported May 27 2014 - Updated May 27 2014 - 1 reports

STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS reported multiple sessions, symposia and case presentations featuring STENTYS Self-Apposing stents during EuroPCR 2014. ... [Published Business Wire Health News - May 27 2014]
Entities: Stentys SA, Stent, Paris
First reported May 20 2014 - Updated May 21 2014 - 1 reports

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS today presented final results from the APPOSITION IV study of its new Self-Apposing sirolimus-eluting stent (SES) during the Hotline session at the EuroPCR conference in Paris. ... [Published Business Wire Health News - May 20 2014]
First reported May 14 2014 - Updated May 14 2014 - 1 reports

STENTYS Secures a Standby Equity Facility

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS today announced that it has entered into a Standby Equity Facility with Société Générale, exercisable by tranches at STENTYS’ discretion. ... [Published Business Wire Health News - May 14 2014]
First reported Apr 29 2014 - Updated Apr 29 2014 - 3 reports

STENTYS’ Self-Apposing Stent Featured in New Article Published by the Journal of the American College of Cardiology

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS' Self-Apposing Stent has been highlighted as a solution to minimize stent malapposition in a new article published by the Journal of the American College of Cardiology. ... [Published Business Wire Science: Science News - Apr 29 2014]

Quotes

Gonzague Issenmann, Chief Executive Officer and co-founder of Stentys, said, "Following a good first half, revenues should continue growing at a steady rate during the second half of the year, primarily as a result of the commercial development in recently opened regions (South America, Asia) and the CE marking of our Sirolimus-eluting stent which is expected before the end of the year."
Gonzague Issenmann, co-founder and Chief Executive Officer of Stentys said: "Dr. Virmani and her colleagues have confirmed that malapposition leads to serious complications for patients with acute coronary syndrome. The Self-Apposing Stent data not only shows greatly reduced rates of malapposition compared with conventional stents but also very low mortality rates."
Gonzague Issenmann, Chief Executive Officer and co-founder of Stentys, said: "After recent expansion into the Middle East in 2013 and Southeast Asia at the beginning of this year, entering into new distributor relationships in South America clearly indicates the successful execution of our worldwide growth strategy. The ramp up in these high-potential emerging markets will be further supported next year by the commercialization of the Sirolimus-eluting stent, which should obtain CE Marking during the second half of 2014."

More Content

All (21) | News (6) | Reports (0) | Blogs (14) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Stentys Posts First Half 2014 Revenues Results [Published Individual.com - Jul 29 2014]
STENTYS First Half 2014 Revenues Rise 18% [Published Business Wire Health News - Jul 24 2014]
Study Shows Malapposition Influences Death from... [Published Diagnostic & Invasive Cardiology - Jul 21 2014]
Stentys Bolsters Marketing of the Self-Apposing... [Published Individual.com - Jul 14 2014]
STENTYS Expands Marketing of the Self-Apposing ... [Published EON: Enhanced Online News - Jul 09 2014]
STENTYS Expands Marketing of the Self-Apposing ... [Published Business Wire Health News - Jul 09 2014]
French Life Sciences Companies Dazzle U.S. Inve... [Published Forbes.com - Jun 30 2014]
STENTYS : Purchases Cappella Peel Away [Published 4 Traders - Jun 22 2014]
STENTYS Completes the Acquisition of Cappella P... [Published Business Wire Health News - Jun 12 2014]
STENTYS to Acquire Stent Delivery Technology fo... [Published Business Wire Health News - Jun 04 2014]
STENTYS Self-Apposing Stent Featured Prominentl... [Published Business Wire Health News - May 27 2014]
STENTYS Sirolimus-Eluting Stent Demonstrates Be... [Published Business Wire Health News - May 20 2014]
STENTYS Secures a Standby Equity Facility [Published Business Wire Health News - May 14 2014]
STENTYS: Journal of the American College of Car... [Published Business Wire Health News - May 06 2014]
STENTYS’ Self-Apposing Stent Featured in New Ar... [Published Business Wire Science: Science News - Apr 29 2014]
STENTYS’ Self-Apposing Stent Featured in New Ar... [Published EON Science - Apr 29 2014]
STENTYS’ Self-Apposing Stent Featured in New Ar... [Published Business Wire Health News - Apr 29 2014]
STENTYS: First Quarter Revenues Up 18% from 2013 [Published Business Wire Health News - Apr 24 2014]
STENTYS Appoints Medical Device Executive to it... [Published Business Wire Health News - Apr 10 2014]
STENTYS Reports 2013 Financial Results [Published Business Wire Health News - Mar 13 2014]
Fact Sheet for Stentys [Published Silobreaker - Sep 03 2010]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
STENTYS First Half 2014 Revenues Rise 18% [Published Business Wire Health News - Jul 24 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS First Half 2014 Revenues Rise 18% ...
STENTYS Expands Marketing of the Self-Apposing ... [Published Business Wire Health News - Jul 09 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS has entered the Latin American coronary stent market, signing agreements to market its Self-Apposing Stent in Argentina, Chile and Colombia. ...
STENTYS Completes the Acquisition of Cappella P... [Published Business Wire Health News - Jun 12 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS has completed its acquisition of Cappella Peel Away Inc. for a total of 1 million Euros in stock and cash. ...
STENTYS to Acquire Stent Delivery Technology fo... [Published Business Wire Health News - Jun 04 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS will acquire a catheter technology for a next-generation delivery system for its Self-Apposing Stent; it has been validated by an extensive number of Cappella Sideguard stent implants. ...
STENTYS Self-Apposing Stent Featured Prominentl... [Published Business Wire Health News - May 27 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS reported multiple sessions, symposia and case presentations featuring STENTYS Self-Apposing stents during EuroPCR 2014. ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.